CY2233B1 - Compositions to treat onychomycoses - Google Patents

Compositions to treat onychomycoses

Info

Publication number
CY2233B1
CY2233B1 CY0100024A CY0100024A CY2233B1 CY 2233 B1 CY2233 B1 CY 2233B1 CY 0100024 A CY0100024 A CY 0100024A CY 0100024 A CY0100024 A CY 0100024A CY 2233 B1 CY2233 B1 CY 2233B1
Authority
CY
Cyprus
Prior art keywords
hcl
antifungal
glycol
agents
penetration
Prior art date
Application number
CY0100024A
Other languages
English (en)
Inventor
Jean-Pierre Laugier
Philippe Touzan
Marie-France Rude
Francois Ringenbach
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY2233B1 publication Critical patent/CY2233B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
CY0100024A 1991-03-08 2001-09-07 Compositions to treat onychomycoses CY2233B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9102838A FR2673537B1 (fr) 1991-03-08 1991-03-08 Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.

Publications (1)

Publication Number Publication Date
CY2233B1 true CY2233B1 (en) 2003-04-18

Family

ID=9410536

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0100024A CY2233B1 (en) 1991-03-08 2001-09-07 Compositions to treat onychomycoses

Country Status (17)

Country Link
US (3) US5814305A (pt)
EP (1) EP0503988B1 (pt)
JP (1) JP3559973B2 (pt)
AT (1) ATE190485T1 (pt)
AU (1) AU1147092A (pt)
BR (1) BR9200786A (pt)
CA (1) CA2062341C (pt)
CY (1) CY2233B1 (pt)
DE (1) DE69230772T2 (pt)
DK (1) DK0503988T3 (pt)
ES (1) ES2144409T3 (pt)
FR (1) FR2673537B1 (pt)
GR (1) GR3033297T3 (pt)
MX (1) MX9200965A (pt)
PT (1) PT503988E (pt)
SG (1) SG46660A1 (pt)
ZA (1) ZA921706B (pt)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5652256A (en) * 1995-06-06 1997-07-29 Knowles; W. Roy Topical composition for fungal treatment
WO1998016251A1 (de) * 1996-10-16 1998-04-23 Ipr-Institute For Pharmaceutical Research Ag Neue carrier-systeme
DK0983037T3 (da) * 1998-02-09 2003-09-01 Macrochem Corp Fungicid neglelak
AU5404399A (en) 1998-09-10 2000-04-03 Ipr-Institute For Pharmaceutical Research Ag Topical application products
US6159977A (en) * 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
US6517863B1 (en) 1999-01-20 2003-02-11 Usbiomaterials Corporation Compositions and methods for treating nails and adjacent tissues
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
GB0019283D0 (en) * 2000-08-04 2000-09-27 Novartis Ag Organic compounds
US6664292B2 (en) 2001-06-04 2003-12-16 Mark H. Bogart Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US6821508B2 (en) 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
US20030049307A1 (en) * 2002-08-15 2003-03-13 Gyurik Robert J. Pharmaceutical composition
AU2003262769A1 (en) * 2002-08-20 2004-03-11 Pinnell, Doren M Methods for treating fungal infections
FR2844197B1 (fr) * 2002-09-05 2006-06-23 Galderma Res & Dev Solution pour application ungueale et peri-ungeale
PT1545619E (pt) * 2002-09-05 2008-02-28 Galderma Sa Solução destinada a uma aplicação sobre as unhas
US20040126343A1 (en) * 2002-12-26 2004-07-01 Garshowitz Solomon David Nail drug delivery
WO2004084826A2 (en) * 2003-03-21 2004-10-07 Nexmed Holdings, Inc. Antifungal nail coat and method of use
WO2004108114A2 (en) * 2003-03-31 2004-12-16 Dinesh Shantilal Patel Anti-fungal composition and a process for its manufacture
WO2005002561A1 (ja) * 2003-07-03 2005-01-13 Taisho Pharmaceutical Co.,Ltd. 外用抗真菌剤組成物
JP4784051B2 (ja) * 2003-07-03 2011-09-28 大正製薬株式会社 容器への吸着を防止した外用抗真菌組成物
AU2004266053B2 (en) * 2003-08-25 2011-06-09 Bioequal Ag Pharmaceutical and cosmetic formulations for treating fingernails
DE10341944A1 (de) * 2003-09-11 2005-04-28 York Pharma Plc Antimykotisch wirksame Nagellackformulierung mit substituierten 2-Aminothiazolen als Wirkstoff
DE602004028284D1 (de) * 2003-12-08 2010-09-02 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078599A1 (en) * 2004-10-12 2006-04-13 Mathew Ebmeier Pharmaceutical composition applicable to body tissue
BRPI0518676A2 (pt) * 2004-11-29 2008-12-02 Ambria Dermatology Ab composiÇço, uso da mesma, e, mÉtodos de fabricar uma composiÇço e de tratar uma infecÇço microbiana
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
BRPI0518999A2 (pt) * 2004-12-10 2008-12-23 Talima Therapeutics Inc composiÇÕes e mÉtodos para tratar condiÇÕes da unidade da unha
US20060165747A1 (en) * 2005-01-24 2006-07-27 David Rolf Antifungal composition, method and kit for topically treating onychomycosis
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
CN103357015A (zh) * 2005-09-29 2013-10-23 瑞士商拜欧伊果公司 疣、指甲疾病、及指甲保养用之局部配方
MXPA05012961A (es) * 2005-11-30 2007-05-30 Fernando Ahumada Ayala Preparaciones para el cuidado de las unas que contienen clorhidrato de terbinafina.
US9579297B2 (en) 2005-12-28 2017-02-28 Teikoku Seiyaku Co., Ltd. Pharmaceutical composition for application to nail
EP1971324A1 (en) * 2006-01-02 2008-09-24 TLT Medical Ltd Pharmaceutical composition for the treatment of nail diseases
US20090215888A1 (en) * 2006-03-02 2009-08-27 Singh Jagat Topical nail formulation
JP5160409B2 (ja) * 2006-03-08 2013-03-13 日本農薬株式会社 外用の医薬組成物
JP4861420B2 (ja) 2006-08-28 2012-01-25 久光製薬株式会社 爪用貼付剤
US20080135643A1 (en) * 2006-12-08 2008-06-12 Kimberly-Clark Worldwide, Inc. Pulsating spray dispensers
US8052984B2 (en) * 2007-02-05 2011-11-08 Biophile Corporation, Ltd. Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
US20080261986A1 (en) * 2007-03-30 2008-10-23 Friden Phillip M Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
CA2683958C (en) 2007-04-20 2014-01-28 Bioequal Ag Topical fungicidal agents for treating nail disorders
US20080287912A1 (en) * 2007-05-14 2008-11-20 Horrigan Corporation Method, Device And Formulation For The Treatment Of Nail Disorders
US20100204293A1 (en) * 2007-09-05 2010-08-12 Pola Pharma Inc. Pharmaceutical composition
EP2191827B1 (en) 2007-09-05 2013-10-30 Pola Pharma Inc. Antifungal composition
PL2191828T3 (pl) * 2007-09-05 2017-02-28 Pola Pharma Inc. Przeciwgrzybicza kompozycja farmaceutyczna
EP2207546A1 (en) * 2007-10-09 2010-07-21 Humco Holding Group, Inc. Antifungal treatment of nails
US7802314B2 (en) * 2007-10-31 2010-09-28 Kimberly-Clark Worldwide, Inc. Hand-wear article with cutaneous sensory elements
US8221370B2 (en) * 2007-10-31 2012-07-17 Kimberly-Clark Worldwide, Inc. Personal care article with substrate surface topography for evoking a neurosensory skin response
WO2009071959A2 (en) * 2007-12-04 2009-06-11 Pannonpharma Gyógyszergyártó Kft. A composition in the form of a paint tincture or lacquer to treat fungal infections containing itraconazole and a process for the preparation thereof
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8193232B2 (en) * 2009-02-13 2012-06-05 Topica Pharmaceuticals, Inc. Anti-fungal formulation
EP2400988B1 (en) 2009-02-26 2016-04-13 B.R.A.I.N. Biotechnology Research and Information Network AG Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
FR2942716B1 (fr) 2009-03-06 2011-04-15 Galderma Res & Dev Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
US20120309753A1 (en) * 2009-03-06 2012-12-06 Galderma Research & Development Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail
EP2416757A2 (en) 2009-04-09 2012-02-15 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102387786B (zh) 2009-04-09 2015-09-09 宝丽制药股份有限公司 抗真菌药物组合物
DE102009038512A1 (de) * 2009-07-30 2011-02-10 Technische Universität Braunschweig Arzneimittelformulierung zur Behandlung von Nagelerkrankungen
WO2011014850A2 (en) * 2009-07-31 2011-02-03 Nuvo Research Inc. Topical eutectic-based formulations
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
NL2003786C2 (en) 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
CN102770123A (zh) 2009-12-23 2012-11-07 纽沃研究股份有限公司 用于治疗甲癣的高渗透性特比萘芬制剂
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
US20120061267A1 (en) * 2010-09-14 2012-03-15 Sally Villalobos MediTowel Anti-Fungal Wipe
EP2462991A1 (en) 2010-12-13 2012-06-13 PQS Group B.V. Composition and use of a fermented olive leaf product for the treatment of nail infections
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
RU2015143995A (ru) 2013-03-14 2017-04-20 Халлюкс, Инк. Способ лечения инфекций, заболеваний или расстройств ногтевого ложа
CN110433291B (zh) 2013-10-03 2023-04-28 博世健康爱尔兰有限公司 稳定的艾菲康唑组合物
CA2931144C (en) 2013-11-22 2020-02-04 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices
WO2016015094A1 (en) * 2014-07-31 2016-02-04 Acrux Dds Pty Ltd Topical composition
US9744156B2 (en) * 2015-08-17 2017-08-29 Arno Therapeutics, Inc. Methods and compositions for enhanced transungual delivery of AR-12
KR20180070607A (ko) * 2015-10-07 2018-06-26 엑소도스 라이프 사이언시스 엘피 항진균 국소 조성물
US10993890B2 (en) * 2018-03-15 2021-05-04 Pelli Skin Co., Llc Antifungal solution and foot wipe
CN108653195A (zh) * 2018-08-08 2018-10-16 江苏知原药业有限公司 透皮或透粘膜给药制剂
EP3897604A4 (en) * 2018-12-19 2022-08-17 Marlinz Pharma, LLC TOPICAL COMPOSITIONS
WO2020231800A1 (en) * 2019-05-10 2020-11-19 Encube Ethicals Private Limited Topical antifungal formulation
EP4129292A1 (en) 2021-08-04 2023-02-08 OnychoPharm GmbH Formulation for substituted 2-aminothiazoles in the treatment of fungal and fungal-bacterial infections of the nail

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
ATE10272T1 (de) * 1979-08-22 1984-11-15 Sandoz Ag Propenylamine, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre verwendung als arzneimittel.
FR2572933B1 (fr) * 1981-04-06 1988-03-18 Sandoz Sa Compositions pharmaceutiques topiques a base de tizanidine
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
JPS6169721A (ja) * 1984-09-13 1986-04-10 Kao Corp 抗真菌組成物
EP0247142B1 (en) * 1985-11-04 1993-01-07 Owen/Galderma Laboratories Inc. Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3783683T2 (de) * 1986-01-31 1993-05-19 Whitby Research Inc Hautpenetration verbessernde zusammensetzungen.
US5256647A (en) * 1986-01-31 1993-10-26 Whitby Research, Inc. Compositions comprising 1-substituted azacycloalkanes
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US4920112A (en) * 1988-04-18 1990-04-24 Merck & Co., Inc. Fungicidal compositions and method
US5181914A (en) * 1988-08-22 1993-01-26 Zook Gerald P Medicating device for nails and adjacent tissue
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
JP2797401B2 (ja) * 1989-04-19 1998-09-17 日産化学工業株式会社 爪用抗真菌剤組成物
FR2646603B1 (fr) * 1989-05-03 1991-07-12 Oreal Composition nettoyante
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US5215520A (en) * 1991-09-17 1993-06-01 Centre Internationale De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Method for delivering an active substance topically or percutaneously
US5661170A (en) * 1994-03-21 1997-08-26 Woodward Laboratories, Inc. Antimicrobial compositions and methods for using the same

Also Published As

Publication number Publication date
GR3033297T3 (en) 2000-09-29
US5814305A (en) 1998-09-29
BR9200786A (pt) 1992-11-17
CA2062341C (fr) 2004-05-11
ZA921706B (en) 1992-11-25
FR2673537B1 (fr) 1993-06-11
SG46660A1 (en) 1998-02-20
AU1147092A (en) 1992-09-10
ATE190485T1 (de) 2000-04-15
FR2673537A1 (fr) 1992-09-11
US6455592B1 (en) 2002-09-24
DE69230772T2 (de) 2000-07-27
JP3559973B2 (ja) 2004-09-02
JPH0585929A (ja) 1993-04-06
DK0503988T3 (da) 2000-07-24
DE69230772D1 (de) 2000-04-20
EP0503988A1 (fr) 1992-09-16
US6143793A (en) 2000-11-07
MX9200965A (es) 1992-09-01
PT503988E (pt) 2000-06-30
EP0503988B1 (fr) 2000-03-15
ES2144409T3 (es) 2000-06-16
CA2062341A1 (fr) 1992-09-09

Similar Documents

Publication Publication Date Title
CY2233B1 (en) Compositions to treat onychomycoses
CA2207212A1 (en) Parasiticide formulations suital for dermal application
EP0129284A3 (en) Improved penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
WO1998042322A3 (en) Antitussive compositions
AU1449497A (en) Cyclosporin formulation
PL311637A1 (en) Poured over preparations containing a polymer as well as glycerides and glycols
IE781032L (en) Pharmaceutical compositions
CA2360300A1 (en) A transdermal composition of an antivomiting agent and a preparation containing the same
AU2603792A (en) Long acting injectable formulations containing hydrogenated castor oil
JPS5750914A (en) Betamethasone external pharmaceutical
AU1768095A (en) Gemfibrozil containing pharmaceutical compositions
WO1998029131A3 (en) Aqueous glycerol formulations of somatotropin
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
KR920702623A (ko) 진해제
AU1783699A (en) Compositions for the transdermal and dermal administration of biologically active agents
EP0685230A4 (en) STABLE DERMATOLOGICAL PREPARATIONS CONTAINING MYCOHENOLIC ACID.
HUT46506A (en) Insecticidal and game repellent synergetic compositions
CA2216700A1 (en) Synergistic pharmaceutical compositions containing triamcinolone acetonide and halcinonide